APA (7th ed.) Citation

Yan, Z., Yang, K., Tang, X., Bi, Y., Ding, Y., Deng, M., . . . Chen, T. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Wiley.

Chicago Style (17th ed.) Citation

Yan, Zijun, Kun Yang, Xiang Tang, Yunfeng Bi, Yuzhen Ding, Mengyue Deng, Die Xia, Yunqi Zhao, and Tong Chen. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Wiley.

MLA (9th ed.) Citation

Yan, Zijun, et al. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Wiley.